Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2590)
All Articles published online
|
Dec 28, 2006 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Ávila FI, Sánchez-Ávila F, Montaño-Reyes MA, Uribe M. Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review. World J Gastroenterol 2006; 12(48): 7826-7831 [PMID: 17203528 DOI: 10.3748/wjg.v12.i48.7826] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i48/7826.htm |
| Number | Citing Articles |
| 1 |
Yong Qi, Kenneth A Longo, Derek J Giuliana, Samantha Gagne, Tom McDonagh, Elizabeth Govek, Anna Nolan, Chaoseng Zou, Kristen Morgan, Jeffrey Hixon, Jeffrey O Saunders, Peter S DiStefano, Brad J Geddes. Characterization of the insulin sensitivity of ghrelin receptor KO mice using glycemic clamps. BMC Physiology 2011; 11(1) doi: 10.1186/1472-6793-11-1
|
| 2 |
Khalid Mahmood, Muhammad Naeem, Nasir Ali Rahimnajjad. Metformin: The hidden chronicles of a magic drug. European Journal of Internal Medicine 2013; 24(1): 20 doi: 10.1016/j.ejim.2012.10.011
|
| 3 |
C. Thiolet, D. Corberand, F. Harnois, D. Mennecier, O. Farret. Complications digestives du diabète. EMC - Gastro-entérologie 2008; 3(1): 1 doi: 10.1016/S1155-1968(08)27498-5
|
| 4 |
Juan P Arab, Roberto Candia, Rodrigo Zapata, Cristián Muñoz, Juan P Arancibia, Jaime Poniachik, Alejandro Soza, Francisco Fuster, Javier Brahm, Edgar Sanhueza, Jorge Contreras, M Carolina Cuellar, Marco Arrese, Arnoldo Riquelme. Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review. World Journal of Gastroenterology 2014; 20(34): 12182-12201 doi: 10.3748/wjg.v20.i34.12182
|
| 5 |
Ivana Mikolasevic, Lidija Orlic, Irena Hrstic, Sandra Milic. Metabolic syndrome and non‐alcoholic fatty liver disease after liver or kidney transplantation. Hepatology Research 2016; 46(9): 841 doi: 10.1111/hepr.12642
|
| 6 |
|
| 7 |
Alexis St. George, Adrian Bauman, Amanda Johnston, Geoffrey Farrell, Tien Chey, Jacob George. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. Journal of Gastroenterology and Hepatology 2009; 24(3): 399 doi: 10.1111/j.1440-1746.2008.05694.x
|
| 8 |
Carolyn C. Brackett. Clarifying metformin's role and risks in liver dysfunction. Journal of the American Pharmacists Association 2010; 50(3): 407 doi: 10.1331/JAPhA.2010.08090
|
| 9 |
Takuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, Akihiro Obora, Takao Kojima, Michiaki Fukui. Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01809-2
|
| 10 |
Chong Yew Tan, Antonio Vidal-Puig. Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochemical Society Transactions 2008; 36(5): 935 doi: 10.1042/BST0360935
|
| 11 |
Masao Omata, Laurentius A. Lesmana, Ryosuke Tateishi, Pei-Jer Chen, Shi-Ming Lin, Haruhiko Yoshida, Masatoshi Kudo, Jeong Min Lee, Byung Ihn Choi, Ronnie T. P. Poon, Shuichiro Shiina, Ann Lii Cheng, Ji-Dong Jia, Shuntaro Obi, Kwang Hyub Han, Wasim Jafri, Pierce Chow, Seng Gee Lim, Yogesh K. Chawla, Unggul Budihusodo, Rino A. Gani, C. Rinaldi Lesmana, Terawan Agus Putranto, Yun Fan Liaw, Shiv Kumar Sarin. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatology International 2010; 4(2): 439 doi: 10.1007/s12072-010-9165-7
|
| 12 |
YAN LI, LEI LIU, BIN WANG, JUN WANG, DONGFENG CHEN. Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Biomedical Reports 2013; 1(1): 57 doi: 10.3892/br.2012.18
|
| 13 |
Ajay Duseja, Ashim Das, Radha Krishan Dhiman, Yogesh Kumar Chawla, Kiran K. Thumburu, Sanjay Bhadada, Anil Bhansali. Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Annals of Hepatology 2007; 6(4): 222 doi: 10.1016/S1665-2681(19)31902-7
|
| 14 |
N.C. Chavez-Tapia, F. Sanchez-Avila, F. Vasquez-Fernandez, A. Torres-Machorro, F.I. Tellez-Avila, M. Uribe. Non-Alcoholic Fatty-Liver Disease in Pediatric Populations. Journal of Pediatric Endocrinology and Metabolism 2007; 20(10) doi: 10.1515/JPEM.2007.20.10.1059
|
| 15 |
Roberto Miccoli, Dieuwke De Keyzer, David Giuseppe Penno, David Stefano Del Prato. Insulin resistance and lipid disorders. Future Lipidology 2008; 3(6): 651 doi: 10.2217/17460875.3.6.651
|
| 16 |
Kassem Bourgi, Celestine Wanjalla, John R. Koethe. Inflammation and Metabolic Complications in HIV. Current HIV/AIDS Reports 2018; 15(5): 371 doi: 10.1007/s11904-018-0411-2
|
| 17 |
Neel S. Singhal, Rajesh T. Patel, Yong Qi, Yun-Sik Lee, Rexford S. Ahima. Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. American Journal of Physiology-Endocrinology and Metabolism 2008; 295(2): E331 doi: 10.1152/ajpendo.00577.2007
|